Letters To The Editor Open Access
Copyright ©2009 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Jan 7, 2009; 15(1): 121-123
Published online Jan 7, 2009. doi: 10.3748/wjg.15.121
Bile duct ligation in rats: A reliable model of hepatorenal syndrome?
Stelios F Assimakopoulos, Department of Internal Medicine, University Hospital of Patras, Patras 26504, Greece
Constantine E Vagianos, First Surgical Department, “Saint Panteleimon” General Hospital of Nikaia, Piraeus 18454, Greece
Author contributions: Assimakopoulos SF wrote this commentary and Vagianos CE revised it.
Correspondence to: Stelios F Assimakopoulos, MD, PhD, Department of Internal Medicine, School of Medicine, University of Patras, Vironos 18, 26224, Patras, Greece. sassim@upatras.gr
Telephone: +30-2610-346946
Fax: +30-2610-990775
Received: October 18, 2008
Revised: December 6, 2008
Accepted: December 13, 2008
Published online: January 7, 2009

Abstract

The two most widely used experimental models of advanced liver disease are the administration of carbon tetrachloride, and common bile duct ligation (BDL), however, neither has been systematically evaluated as a model of hepatorenal syndrome (HRS). The BDL model in rats, studied at diverse time points, induced a progressive renal dysfunction without structural changes in the kidney. The authors concluded that BDL is a good model for further studies of HRS and its treatment. However, the renal impairment observed at the acute phase of the BDL model is based on a different pathophysiology than that of HRS. Specifically, in acute obstructive jaundice, cholemia predominates over parenchymal liver disease (reversible at this stage without portal hypertension or cirrhosis) and independently induces negative inotropic and chronotropic effects on the heart, impaired sympathetic vasoconstriction response and profound natriuresis and diuresis that might lead to volume depletion. In addition, systemic endotoxemia contributes to the prerenal etiology of renal impairment and promotes direct nephrotoxicity and acute tubular necrosis. On the other hand, the renal failure observed in the chronic BDL model (with development of biliary cirrhosis, portal hypertension and ascites) shares pathophysiological similarities with HRS, but the accordance of the chronic BDL model to the diagnostic criteria of HRS (e.g. absence of spontaneous bacterial peritonitis, no renal function improvement after plasma volume expansion) should have been confirmed. In conclusion, we think that the BDL model is not suitable for the study of the natural history of HRS, but the chronic BDL model might be valid for the study of established HRS and its potential therapies.

Key Words: Obstructive jaundice; Rats; Bile duct ligation; Hepatorenal syndrome; Renal failure



TO THE EDITOR

We read with great interest the article recently published in World J Gastroenterol by Dr. Pereira et al[1], which evaluated the reliability of the bile duct ligation (BDL) model in rats for the study of hepatorenal syndrome (HRS). The authors found that this experimental model induces progressive renal dysfunction without structural changes in the kidney, and they suggested that BDL in rats emerges as a good model for further studies of HRS pathophysiology and treatment. Upon reading this very interesting study, a number of questions a rose as to whether the renal dysfunction observed after BDL really represents HRS.

HRS is defined as a specific type of functional renal failure complicating advanced liver disease (e.g. decompensated cirrhosis, alcoholic hepatitis, or acute liver failure)[23]. The pathogenesis of this syndrome is the result of an extreme underfilling of the arterial circulation secondary to an arterial vasodilation located in the splachnic circulation. This underfilling triggers a compensatory response with activation of vasoconstrictor systems leading to intense renal vasoconstriction, especially to the renal cortex, and finally the glomerular filtration rate is decreased in the absence of underlying kidney pathology whilst tubular function is preserved[4]. Consequently, this specific type of functional renal failure observed in advanced liver disease must be differentiated by a number of non-functional causes of renal failure in this setting, e.g., other causes of prerenal azotemia or acute tubular necrosis[34]. The distinction between HRS and other causes of renal failure that may occur in cirrhosis is problematic mainly due to the lack of a specific diagnostic test. A number of commonly used urinary indices (e.g. urinary sodium or osmolarity) cannot reliably distinguish HRS and acute tubular necrosis in the setting of cirrhosis, making this differentiation especially difficult[34]. For these reasons, the diagnosis of HRS is currently based on the exclusion of other disorders that could lead to renal failure in cirrhosis including shock (septic or hypovolemic), ongoing bacterial infection, fluid losses and current treatment with nephrotoxic drugs[4]. An additional major criterion that should be fulfilled is that no sustained improvement in renal function occurs after expansion of plasma volume. In their study, the authors have not examined the accordance of the BDL model with these criteria, instead they characterize the BDL-induced renal dysfunction as “HRS” based solely on the absence of histopathological changes in the kidneys and on evaluation of diverse urinary indices. The histological analyses performed in the kidney are not described in detail but it is generally stated that BDL rats exhibited normal renal histology under the light microscope. This finding contradicts most previously published reports, which describe significant histological alterations, predominantly located in tubular epithelial cells, at various intervals of obstructive jaundice[510]. Furthermore, as already stated, urinary indices represent only minor and dispensable criteria for the diagnosis of HRS[4]. Taking into consideration these issues, a number of uncertainties are raised regarding the reliability of the BDL model for the study of HRS, which become more evident when considering the pathophysiology of renal failure complicating obstructive jaundice.

In rats, double ligation of the common bile duct with its dissection between the ligatures produces a well established experimental model of: (1) acute obstructive jaundice, studying different time points up to 2 wk after BDL; (2) progression of biliary fibrosis to cirrhosis, studying diverse time intervals up to 4 or 6 wk after BDL; and (3) secondary biliary cirrhosis, at 4 or 6 wk after BDL[1112]. BDL produces a combined model of cholemia and parenchymal liver disease. The magnitude of contribution of any one factor in remote organ injury and systemic complications depends on the duration of the biliary obstruction. In acute obstructive jaundice, the liver presents typical changes of obstructive cholangiopathy, in the absence of cirrhosis or portal hypertension, which are at least partly reversible if biliary drainage is performed at this stage[1314]. This initial phase of surgical jaundice is characterized by the effects of severe cholestasis and cholemia due to total obstruction of bile flow, with intestinal barrier failure and decreased reticuloendothelial system function. This predisposes the test subject to portal and systemic endotoxemia and susceptibility to postoperative septic complications and renal dysfunction[1516]. Severe cholemia, predominantly and independently of liver parenchymal disease, affects the integrity of the cardiovascular system by inducing;s (1) negative inotropic and chronotropic effects on the heart[1718]; (2) impaired sympathetic vasoconstriction response[1920]; and (3) profound natriuresis and diuresis that may lead to volume depletion[2122]. These factors produce systemic hypotension and renal dysfunction, especially when an interventional approach for the release of biliary obstruction is performed[22]. The etiology of renal impairment in this setting is profoundly prerenal and occurs in the absence of advanced and irreversible liver disease. In addition, it has been shown repeatedly that acute obstructive jaundice is universally complicated by extended bacterial translocation with portal and systemic endotoxemia[2325]. These phenomena activate a systemic inflammatory response characterized by the release of numerous cytokines and proinflammatory mediators, which may lead to the development of the septic syndrome and multiple organ damage[26]. Endotoxin-induced renal injury is not only functional, through induction of a hypotensive response, but endotoxin also exerts direct nephrotoxic effects. The result is renal injury clearly characterized by histological alterations of acute tubular necrosis[2728]. Given the central role of endotoxemia in obstructive-jaundice-induced systemic complications[1625], we would expect that renal failure in obstructive jaundice would be accompanied by tubular injury. Despite the authors’ findings of normal renal histology in BDL rats, there are numerous previous studies showing that the acute BDL model induces renal histopathological changes, predominantly in the tubular epithelium (acute tubular necrosis)[510]. For all these reasons, we think that the pathogenesis and the type of renal dysfunction that is observed during the acute phase of BDL are different from what we mean by the term HRS.

With regard to the chronic phase of BDL (after 4 wk of biliary obstruction), apart from cholemia, the factor severe parenchymal liver disease comes into play, significantly contributing to renal dysfunction[22]. This phase is characterized by development of biliary cirrhosis with portal hypertension, and ascites and more closely resembles clinical conditions complicated by HRS[11]. However, cholemia still exists to a considerable extent and acts on renal hemodynamics. Endotoxemia, with its consecutive systemic inflammatory response and bacterial translocation to remote organs, also exists, interacting with advanced liver disease per se in the development of renal dysfunction. Is the final result on kidney the development of HRS? In order to give a reliable answer to this question we should examine the accordance of the BDL model with the well-established diagnostic criteria of HRS, as we would do in a clinical setting. Rats with BDL for more than 4 wk are cirrhotic with ascites and have increased rates of bacterial translocation; therefore, spontaneous bacterial peritonitis should be excluded as an underlying cause of renal failure. We should also demonstrate the lack of response of renal function to volume repletion by isotonic saline. If these prerequisites are fulfilled, we would be more certain to characterize the renal failure observed in the chronic phase of BDL as HRS.

In conclusion, we think that the BDL model is not suitable for the study of the natural history of HRS, because at the acute phase of extrahepatic cholestasis, the pathophysiology of the observed renal impairment seems to be different from that of HRS. However, renal failure observed in the chronic BDL model shares pathophysiological similarities with HRS. The accordance of the chronic BDL model to the diagnostic criteria of HRS, if confirmed, may provide us with a valuable experimental model for the study of established HRS and its potential therapies. Another important issue that remains to be elucidated is the comparison of the BDL model with the carbon tetrachloride model of cirrhosis, in order to examine the potential superiority of one model over the other for the study of HRS.

Footnotes

S- Editor Tian L L- Editor Stewart GJ E- Editor Lin YP

References
1.  Pereira RM, dos Santos RA, Oliveira EA, Leite VH, Dias FL, Rezende AS, Costa LP, Barcelos LS, Teixeira MM, Simoes e Silva AC. Development of hepatorenal syndrome in bile duct ligated rats. World J Gastroenterol. 2008;14:4505-4511.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Epstein M. Hepatorenal syndrome: emerging perspectives. Semin Nephrol. 1997;17:563-575.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Gines P, Guevara M, Arroyo V, Rodes J. Hepatorenal syndrome. Lancet. 2003;362:1819-1827.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Cardenas A. Hepatorenal syndrome: a dreaded complication of end-stage liver disease. Am J Gastroenterol. 2005;100:460-467.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Ozturk H, Eken H, Ozturk H, Buyukbayram H. Effects of dexamethasone on small bowel and kidney oxidative stress and histological alterations in bile duct-ligated rats. Pediatr Surg Int. 2006;22:709-718.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Kucuk C, Sozuer E, Ikizceli I, Avsarogullari L, Keceli M, Akgun H, Muhtaroglu S. Role of oxygen free radical scavengers in acute renal failure complicating obstructive jaundice. Eur Surg Res. 2003;35:143-147.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Yuceyar S, Gumustas K, Erturk S, Hamzaoglu IH, Uygun N, Ayaz M, Cengiz A, Kafadar Y. The role of oxygen free radicals in acute renal failure complicating obstructive jaundice: an experimental study. HPB Surg. 1998;10:387-393.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Kramer HJ, Schwarting K, Backer A, Meyer-Lehnert H. Renal endothelin system in obstructive jaundice: its role in impaired renal function of bile-duct ligated rats. Clin Sci (Lond). 1997;92:579-585.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Fletcher MS, Westwick J, Kakkar VV. Endotoxin, prostaglandins and renal fibrin deposition in obstructive jaundice. Br J Surg. 1982;69:625-629.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Rodrigo R, Avalos N, Orellana M, Bosco C, Thielemann L. Renal effects of experimental obstructive jaundice: morphological and functional assessment. Arch Med Res. 1999;30:275-285.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Geerts AM, Vanheule E, Praet M, Van Vlierberghe H, De Vos M, Colle I. Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation. Int J Exp Pathol. 2008;89:251-263.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol. 1984;65:305-311.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Matsumoto Y, Niimoto S, Katayama K, Hirose K, Yamaguchi A, Torigoe K. Effects of biliary drainage in obstructive jaundice on microcirculation, phagocytic activity, and ultrastructure of the liver in rats. J Hepatobiliary Pancreat Surg. 2002;9:360-366.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Li W, Chung SC. An improved rat model of obstructive jaundice and its reversal by internal and external drainage. J Surg Res. 2001;101:4-15.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Ding JW, Andersson R, Soltesz V, Willen R, Bengmark S. Obstructive jaundice impairs reticuloendothelial function and promotes bacterial translocation in the rat. J Surg Res. 1994;57:238-245.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Assimakopoulos SF, Scopa CD, Vagianos CE. Pathophysiology of increased intestinal permeability in obstructive jaundice. World J Gastroenterol. 2007;13:6458-6464.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Joubert P. An in vivo investigation of the negative chronotropic effect of cholic acid in the rat. Clin Exp Pharmacol Physiol. 1978;5:1-8.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Liu H, Ma Z, Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology. 2000;118:937-944.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Jacob G, Said O, Finberg J, Bomzon A. Peripheral vascular neuroeffector mechanisms in experimental cholestasis. Am J Physiol. 1993;265:G579-G586.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Bomzon A, Gali D, Better OS, Blendis LM. Reversible suppression of the vascular contractile response in rats with obstructive jaundice. J Lab Clin Med. 1985;105:568-572.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Heidenreich S, Brinkema E, Martin A, Dusing R, Kipnowski J, Kramer HJ. The kidney and cardiovascular system in obstructive jaundice: functional and metabolic studies in conscious rats. Clin Sci (Lond). 1987;73:593-599.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Green J, Better OS. Systemic hypotension and renal failure in obstructive jaundice-mechanistic and therapeutic aspects. J Am Soc Nephrol. 1995;5:1853-1871.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Deitch EA, Sittig K, Li M, Berg R, Specian RD. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg. 1990;159:79-84.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Clements WD, Erwin P, McCaigue MD, Halliday I, Barclay GR, Rowlands BJ. Conclusive evidence of endotoxaemia in biliary obstruction. Gut. 1998;42:293-299.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Clements WD, Parks R, Erwin P, Halliday MI, Barr J, Rowlands BJ. Role of the gut in the pathophysiology of extrahepatic biliary obstruction. Gut. 1996;39:587-593.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg. 1992;216:117-134.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Heemskerk S, Pickkers P, Bouw MP, Draisma A, van der Hoeven JG, Peters WH, Smits P, Russel FG, Masereeuw R. Upregulation of renal inducible nitric oxide synthase during human endotoxemia and sepsis is associated with proximal tubule injury. Clin J Am Soc Nephrol. 2006;1:853-862.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Memis D, Hekimoglu S, Sezer A, Altaner S, Sut N, Usta U. Curcumin attenuates the organ dysfunction caused by endotoxemia in the rat. Nutrition. 2008;24:1133-1138.  [PubMed]  [DOI]  [Cited in This Article: ]